EHAA – an alliance representing over 2 million health professionals in Europe – works to reduce the harmful impacts of alcohol. It advocates for evidence-based policies that prevent harm, protect health, and save lives.
EASL policy statements review the epidemiology of liver disease and analyse the main risk factors to identify effective public health interventions. They are designed to inform decisions and support actions that reduce the burden of liver disease.
Viral hepatitis elimination requires action across healthcare, policy, public health, and patient communities. Through the Viral HOPE programme, EASL brings these stakeholders together to accelerate progress towards hepatitis elimination.
The Collaborating Centre is a tripartite partnership between the World Health Organization, Imperial College London, and EASL. Together, the partners will translate the WHA79 resolution into concrete national action.
HLHL – a coalition between EASL, AASLD, ALEH, APASL, and SOLDA – provides a shared platform for collaboration on global Steatotic Liver Disease priorities where a united voice can help drive meaningful change.
